;
Skip to main content
Home > BioCentury on BioBusiness > Analysts

Chronological Index of : Analyst Picks & Changes

 Current Issue
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/24 cls Galenica Ltd. (SIX:GALN) UBS Guillaume van Renterghem Upgrade Neutral (from sell) 5% CHF797.5 Renterghem upgraded as …

    Published on 10/27/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/17 cls Endo International plc (NASDAQ:ENDP; TSX:ENL) Cantor Fitzgerald Irina Rivkind Koffler Upgrade Hold (from sell) -4% $61.62 …

    Published on 10/20/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/10 cls Arrowhead Research Corp. (NASDAQ:ARWR) RBC Capital Markets Michael Yee Downgrade Sector performer (from outperform) -55% $6.…

    Published on 10/13/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/3 cls AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) Baird Christopher Raymond Price target Outperform 39% $32.27 Jefferies Eun Yang …

    Published on 10/6/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/26 cls Acorda Therapeutics Inc. (NASDAQ:ACOR) Cowen Phil Nadeau Price target Outperform 19% $35.62 ISI Group Mark Schoenebaum …

    Published on 9/29/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/19 cls Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) Leerink Partners Joseph Schwartz Downgrade Market perform (from outperform) 39% $…

    Published on 9/22/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/12cls BioDelivery Sciences International Inc. (NASDAQ:BDSI) Summer Street Jim Molloy Price target Buy 11% $18.15 Molloy raised his …

    Published on 9/15/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/5cls Exelixis Inc. (NASDAQ:EXEL) Cowen Eric Schmidt Downgrade Market perform (from outperform) -55% $1.85 Piper Jaffray Edward …

    Published on 9/8/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/29 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Deutsche Bank Robyn Karnauskas Upgrade Buy (from hold) 19% $11.57 Karnauskas …

    Published on 9/1/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/15 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Piper Jaffray Edward Tenthoff Upgrade Overweight (from neutral) 26% $9.25 Wells…

    Published on 8/18/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/8 cls Alexza Pharmaceuticals Inc. (NASDAQ:ALXA) Roth Capital Partners Scott Henry Downgrade Neutral (from buy) -16% $4.04 Henry …

    Published on 8/11/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/1 cls AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) Piper Jaffray David Amsellem Downgrade Neutral (from overweight) -36% $6.89 …

    Published on 8/4/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/25 cls Gilead Sciences Inc. (NASDAQ:GILD) BMO Capital Markets Jim Birchenough Price target Outperform 1% $89.84 Birchenough raised …

    Published on 7/28/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/18 cls Genfit S.A. (Euronext:GNFT) Deutsche Bank Alethia Young New Buy 23% €29.50 Young initiated coverage with a €110 target on …

    Published on 7/21/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/11 cls Amicus Therapeutics Inc. (NASDAQ:FOLD) Janney Capital Markets Kimberly Lee Upgrade Buy (from hold) -1% $3.96 Leerink …

    Published on 7/14/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/27 cls BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Wells Fargo Brian Abrahams Upgrade Outperform (from market perform) 6% $12.52 …

    Published on 6/30/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/20 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Maxim Group Jason Kolbert Price target Buy 26% $8.13 Kolbert raised his target …

    Published on 6/23/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/13 cls Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) Baird Brian Skorney Upgrade Outperform (from neutral) 125% $6.47 UBS Andrew …

    Published on 6/16/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/6 cls Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) Credit Suisse Jason Kantor New Outperform 46% $15.72 Leerink Partners Joseph …

    Published on 6/9/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/30 cls Acura Pharmaceuticals Inc. (NASDAQ:ACUR) MLV Graig Suvannavejh Downgrade Hold (from buy) -14% $1.06 Suvannavejh also lowered…

    Published on 6/2/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/23 cls InterMune Inc. (NASDAQ:ITMN) Leerink Partners Howard Liang Upgrade Outperform (from market perform) 17% $39.98 Stifel, …

    Published on 5/26/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/16 cls Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) Summer Street Jim Molloy New Buy 19% $280.26 Molloy initiated coverage with a $…

    Published on 5/19/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/9 cls Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Cowen Nicholas Bishop Downgrade Market perform (from outperform) -25% $32.62 …

    Published on 5/12/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/2cls Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) Bernstein Research Geoffrey Porges Upgrade Outperform (from market perform) 1% $155.…

    Published on 5/5/2014
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 4/25 cls BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Brinson Patrick Christopher James New Market outperform -4% $8.01 James …

    Published on 4/28/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993